Lindsey C. is currently the Executive Director of Sterility Assurance at Eli Lilly and Company, where they oversee microbial control strategies for sterile drug product manufacturing. Previously, they held various leadership roles in microbiology and quality assurance at Bristol Myers Squibb and other pharmaceutical companies, including interim Site Head of Quality. Lindsey has a strong background in aseptic processing and has contributed significantly to microbial control within the industry. They possess extensive expertise in quality control and microbiological testing from their time at Pfizer and Merck.
This person is not in any teams
This person is not in any offices